PMID: 22360349

Mandal D, Moitra K, Ghosh D, Xia D, Dey S
Evidence for modulatory sites at the lipid-protein interface of the human multidrug transporter P-glycoprotein.
Biochemistry. 2012 Apr 3;51(13):2852-66. Epub 2012 Mar 22., [PubMed]
Sentences
No. Mutations Sentence Comment
28 ABCB1 p.Gln990Ala
X
ABCB1 p.Gln990Ala 22360349:28:328
status: NEW
view ABCB1 p.Gln990Ala details
ABCB1 p.Val988Ala
X
ABCB1 p.Val988Ala 22360349:28:320
status: NEW
view ABCB1 p.Val988Ala details
ABCB1 p.Met986Ala
X
ABCB1 p.Met986Ala 22360349:28:312
status: NEW
view ABCB1 p.Met986Ala details
ABCB1 p.Val991Ala
X
ABCB1 p.Val991Ala 22360349:28:340
status: NEW
view ABCB1 p.Val991Ala details
ABCB1 p.Phe983Ala
X
ABCB1 p.Phe983Ala 22360349:28:304
status: NEW
view ABCB1 p.Phe983Ala details
ABCB1 p.Thr945Ala
X
ABCB1 p.Thr945Ala 22360349:28:288
status: NEW
view ABCB1 p.Thr945Ala details
ABCB1 p.Met948Ala
X
ABCB1 p.Met948Ala 22360349:28:296
status: NEW
view ABCB1 p.Met948Ala details
ABCB1 p.Ile765Ala
X
ABCB1 p.Ile765Ala 22360349:28:216
status: NEW
view ABCB1 p.Ile765Ala details
ABCB1 p.Ile764Ala
X
ABCB1 p.Ile764Ala 22360349:28:208
status: NEW
view ABCB1 p.Ile764Ala details
ABCB1 p.Ala871Phe
X
ABCB1 p.Ala871Phe 22360349:28:280
status: NEW
view ABCB1 p.Ala871Phe details
ABCB1 p.Leu772Ala
X
ABCB1 p.Leu772Ala 22360349:28:240
status: NEW
view ABCB1 p.Leu772Ala details
ABCB1 p.Gly723Ala
X
ABCB1 p.Gly723Ala 22360349:28:200
status: NEW
view ABCB1 p.Gly723Ala details
ABCB1 p.Ile840Ala
X
ABCB1 p.Ile840Ala 22360349:28:256
status: NEW
view ABCB1 p.Ile840Ala details
ABCB1 p.Ile864Ala
X
ABCB1 p.Ile864Ala 22360349:28:264
status: NEW
view ABCB1 p.Ile864Ala details
ABCB1 p.Val715Ala
X
ABCB1 p.Val715Ala 22360349:28:176
status: NEW
view ABCB1 p.Val715Ala details
ABCB1 p.Ile768Ala
X
ABCB1 p.Ile768Ala 22360349:28:224
status: NEW
view ABCB1 p.Ile768Ala details
ABCB1 p.Phe716Ala
X
ABCB1 p.Phe716Ala 22360349:28:184
status: NEW
view ABCB1 p.Phe716Ala details
ABCB1 p.Ile719Ala
X
ABCB1 p.Ile719Ala 22360349:28:192
status: NEW
view ABCB1 p.Ile719Ala details
ABCB1 p.Ile867Ala
X
ABCB1 p.Ile867Ala 22360349:28:272
status: NEW
view ABCB1 p.Ile867Ala details
ABCB1 p.Phe770Ala
X
ABCB1 p.Phe770Ala 22360349:28:232
status: NEW
view ABCB1 p.Phe770Ala details
ABCB1 p.Thr837Ala
X
ABCB1 p.Thr837Ala 22360349:28:248
status: NEW
view ABCB1 p.Thr837Ala details
The desired nucleotide replacements were confirmed by Big-Dye version 3.1 (BD Sciences) nucleotide sequencing of the MDR1 open reading frame in recombinant plasmids pKM2-MDR1- V715A, -F716A, -I719A, -G723A, -I764A, -I765A, -I768A, -F770A, -L772A, -T837A, -I840A, -I864A, -I867A, -A871F, -T945A, -M948A, -F983A, -M986A, -V988A, -Q990A, and -V991A. Login to comment
99 ABCB1 p.Ile765Ala
X
ABCB1 p.Ile765Ala 22360349:99:124
status: NEW
view ABCB1 p.Ile765Ala details
ABCB1 p.Ile764Ala
X
ABCB1 p.Ile764Ala 22360349:99:135
status: NEW
view ABCB1 p.Ile764Ala details
ABCB1 p.Leu772Ala
X
ABCB1 p.Leu772Ala 22360349:99:103
status: NEW
view ABCB1 p.Leu772Ala details
ABCB1 p.Gly723Ala
X
ABCB1 p.Gly723Ala 22360349:99:63
status: NEW
view ABCB1 p.Gly723Ala details
ABCB1 p.Val715Ala
X
ABCB1 p.Val715Ala 22360349:99:88
status: NEW
view ABCB1 p.Val715Ala details
ABCB1 p.Ile768Ala
X
ABCB1 p.Ile768Ala 22360349:99:117
status: NEW
view ABCB1 p.Ile768Ala details
ABCB1 p.Phe716Ala
X
ABCB1 p.Phe716Ala 22360349:99:77
status: NEW
view ABCB1 p.Phe716Ala details
ABCB1 p.Ile719Ala
X
ABCB1 p.Ile719Ala 22360349:99:70
status: NEW
view ABCB1 p.Ile719Ala details
ABCB1 p.Phe770Ala
X
ABCB1 p.Phe770Ala 22360349:99:110
status: NEW
view ABCB1 p.Phe770Ala details
As one can see in Figure 2A, none of the substitutions in TM7 (G723A, I719A, F716A, and V715A) or TM8 (L772A, F770A, I768A, I765A, and I764A) was critical for stimulation of [125 I]IAAP binding by cis-(Z)-flupentixol. Login to comment
102 ABCB1 p.Gln990Ala
X
ABCB1 p.Gln990Ala 22360349:102:116
status: NEW
view ABCB1 p.Gln990Ala details
ABCB1 p.Val988Ala
X
ABCB1 p.Val988Ala 22360349:102:98
status: NEW
view ABCB1 p.Val988Ala details
ABCB1 p.Met986Ala
X
ABCB1 p.Met986Ala 22360349:102:105
status: NEW
view ABCB1 p.Met986Ala details
ABCB1 p.Phe983Ala
X
ABCB1 p.Phe983Ala 22360349:102:91
status: NEW
view ABCB1 p.Phe983Ala details
ABCB1 p.Met948Ala
X
ABCB1 p.Met948Ala 22360349:102:84
status: NEW
view ABCB1 p.Met948Ala details
A comparable level of basal binding of [125 I]IAAP to wild-type Pgp and Pgp mutants M948A, F983A, V988A, M986A, and Q990A (Figure 2B) rules out the possibility that the reduced level of stimulation in the mutants is due to loss of [125 I]IAAP binding and not stimulation per se. To investigate whether M948, Q990, F983, M986, and V988 are part of a general module involved in the regulation of substrate binding or are molecular components specific to cis- (Z)-flupentixol, we studied the effect of a structurally unrelated Pgp modulator, cyclosporin A, on binding of [125 I]IAAP to all 21 mutants. Login to comment
110 ABCB1 p.Gln990Ala
X
ABCB1 p.Gln990Ala 22360349:110:1575
status: NEW
view ABCB1 p.Gln990Ala details
ABCB1 p.Val988Ala
X
ABCB1 p.Val988Ala 22360349:110:1506
status: NEW
view ABCB1 p.Val988Ala details
ABCB1 p.Met986Ala
X
ABCB1 p.Met986Ala 22360349:110:1438
status: NEW
view ABCB1 p.Met986Ala details
ABCB1 p.Val991Ala
X
ABCB1 p.Val991Ala 22360349:110:1646
status: NEW
view ABCB1 p.Val991Ala details
ABCB1 p.Phe983Ala
X
ABCB1 p.Phe983Ala 22360349:110:1367
status: NEW
view ABCB1 p.Phe983Ala details
ABCB1 p.Thr945Ala
X
ABCB1 p.Thr945Ala 22360349:110:1250
status: NEW
view ABCB1 p.Thr945Ala details
ABCB1 p.Met948Ala
X
ABCB1 p.Met948Ala 22360349:110:1319
status: NEW
view ABCB1 p.Met948Ala details
ABCB1 p.Ile765Ala
X
ABCB1 p.Ile765Ala 22360349:110:715
status: NEW
view ABCB1 p.Ile765Ala details
ABCB1 p.Ile764Ala
X
ABCB1 p.Ile764Ala 22360349:110:649
status: NEW
view ABCB1 p.Ile764Ala details
ABCB1 p.Ala871Phe
X
ABCB1 p.Ala871Phe 22360349:110:1226
status: NEW
view ABCB1 p.Ala871Phe details
ABCB1 p.Leu772Ala
X
ABCB1 p.Leu772Ala 22360349:110:900
status: NEW
view ABCB1 p.Leu772Ala details
ABCB1 p.Gly723Ala
X
ABCB1 p.Gly723Ala 22360349:110:579
status: NEW
view ABCB1 p.Gly723Ala details
ABCB1 p.Ile840Ala
X
ABCB1 p.Ile840Ala 22360349:110:1026
status: NEW
view ABCB1 p.Ile840Ala details
ABCB1 p.Ile864Ala
X
ABCB1 p.Ile864Ala 22360349:110:1094
status: NEW
view ABCB1 p.Ile864Ala details
ABCB1 p.Val715Ala
X
ABCB1 p.Val715Ala 22360349:110:396
status: NEW
view ABCB1 p.Val715Ala details
ABCB1 p.Ile768Ala
X
ABCB1 p.Ile768Ala 22360349:110:763
status: NEW
view ABCB1 p.Ile768Ala details
ABCB1 p.Ile719Ala
X
ABCB1 p.Ile719Ala 22360349:110:510
status: NEW
view ABCB1 p.Ile719Ala details
ABCB1 p.Ile867Ala
X
ABCB1 p.Ile867Ala 22360349:110:1154
status: NEW
view ABCB1 p.Ile867Ala details
ABCB1 p.Phe770Ala
X
ABCB1 p.Phe770Ala 22360349:110:831
status: NEW
view ABCB1 p.Phe770Ala details
ABCB1 p.Thr837Ala
X
ABCB1 p.Thr837Ala 22360349:110:968
status: NEW
view ABCB1 p.Thr837Ala details
Stimulation of ATP Hydrolysis by cis-(Z)-Flupentixol and Verapamil cis-(Z)-flupentixol-mediated stimulation verapamil-mediated stimulation maximal stimulation (x-fold basal) concentration for half-maximal stimulation (μM) remark maximal stimulation (x-fold basal) concentration for half-maximal stimulation (μM) remark WT 7.3 ± 0.4 6.8 ± 1.5 5.6 ± 0.19 6.6 ± 1.04 V715A 6.2 ± 0.2 5.0 ± 0.9 6.4 ± 0.37 16.3 ± 3.3 V716A 5.1 ± 0.2 4.7 ± 1.1 NDb NDb a I719A 4.6 ± 0.08 4.7 ± 0.4 5.8 ± 0.26 6.5 ± 1.31 G723A 5.3 ± 0.3 10.93 ± 2.7 5.4 ± 0.1 11.6 ± 0.88 I764A 4.5 ± 0.4 4.1 ± 2 3.2 ± 0.26 27.9 ± 8.4 I765A 4.96 ± 0.2 2.3 ± 0.47 NDb NDb a I768A 4.8 ± 0.2 1.2 ± 0.43 4.8 ± 0.19 8.5 ± 1.4 F770A 6.6 ± 0.6 10.9 ± 3.9 8.6 ± 0.59 13.2 ± 3.2 L772A 3.6 ± 0.2 2.96 ± 0.9 3.2 ± 0.11 9.5 ± 1.6 T837A 1.1 ± 0.06 NDb a 2.6 ± 0.1 3.1 ± 0.9 I840A 4.0 ± 0.3 25.6 ± 6.5 6.9 ± 0.2 13.5 ± 0.5 I864A 0.6 ± 0.05 NDb a 4.1 ± 0.25 0.9 ± 1.04 I867A 10.2 ± 1.3 72.3 ± 18.5 10.2 ± 0.52 30.7 ± 3.1 A871F NDb NDb NDb NDb a T945A 5.0 ± 0.3 13.7 ± 3.1 6.4 ± 0.15 6.9 ± 0.71 M948A NDb NDb a 6.8 ± 1.5 44.4 ± 12.4 F983A 4.95 ± 0.36 19.59 ± 5.0 6.1 ± 0.38 6.6 ± 1.8 M986A 3.8 ± 0.3 2.6 ± 1.5 7.7 ± 0.76 30.0 ± 8.6 V988A 3.0 ± 0.2 21.4 ± 7.6 6.5 ± 0.31 16.9 ± 2.9 Q990A 1.8 ± 0.4 18.9 ± 2.6 a 7.7 ± 0.58 12.9 ± 3.7 V991A 3.9 ± 0.2 21.1 ± 5.0 5.9 ± 0.59 21.9 ± 7.2 a Mutants with <2-fold maximal stimulation (<25% of the wild-type level). Login to comment
113 ABCB1 p.Val988Ala
X
ABCB1 p.Val988Ala 22360349:113:73
status: NEW
view ABCB1 p.Val988Ala details
ABCB1 p.Ala871Phe
X
ABCB1 p.Ala871Phe 22360349:113:62
status: NEW
view ABCB1 p.Ala871Phe details
ABCB1 p.Ile867Ala
X
ABCB1 p.Ile867Ala 22360349:113:55
status: NEW
view ABCB1 p.Ile867Ala details
Although a moderate effect was observed in Pgp mutants I867A, A871F, and V988A, none of the replacements proved to be absolutely critical for inhibition by cyclosporin A (Figure 3). Login to comment
135 ABCB1 p.Ile764Ala
X
ABCB1 p.Ile764Ala 22360349:135:74
status: NEW
view ABCB1 p.Ile764Ala details
ABCB1 p.Leu772Ala
X
ABCB1 p.Leu772Ala 22360349:135:64
status: NEW
view ABCB1 p.Leu772Ala details
Although a moderate loss of stimulation was observed in mutants L772A and I764A, a >2-fold residual activity in each case suggested that neither of the two residues was indispensable. Login to comment
137 ABCB1 p.Ala871Phe
X
ABCB1 p.Ala871Phe 22360349:137:48
status: NEW
view ABCB1 p.Ala871Phe details
This, however, was with the exception of mutant A871F, which replaced a naturally occurring alanine with a phenylalanine. Login to comment
138 ABCB1 p.Ala871Phe
X
ABCB1 p.Ala871Phe 22360349:138:35
status: NEW
view ABCB1 p.Ala871Phe details
The more general effect evident in A871F most likely represented a local structural perturbation caused by replacement of the methyl side chain of alanine with a bulkier benzyl functional group of phenylalanine. Login to comment
200 ABCB1 p.Gln990Ala
X
ABCB1 p.Gln990Ala 22360349:200:201
status: NEW
view ABCB1 p.Gln990Ala details
ABCB1 p.Ile864Ala
X
ABCB1 p.Ile864Ala 22360349:200:191
status: NEW
view ABCB1 p.Ile864Ala details
As one can see in the top panels (middle and right) of Figure 8, the negative synergistic effect of cis-(Z)-flupentixol on verapamil-stimulated ATP hydrolysis was considerably compromised in I864A and Q990A, Pgp mutants defective with respect to ATP-site stimulation by cis-(Z)-flupentixol. Login to comment
201 ABCB1 p.Ile765Ala
X
ABCB1 p.Ile765Ala 22360349:201:162
status: NEW
view ABCB1 p.Ile765Ala details
Reciprocally, the inhibitory effect of verapamil on cis-(Z)-flupentixol-mediated stimulation of the ATP site was obliterated in the verapamil-specific Pgp mutant I765A (Figure 8, bottom right). Login to comment
205 ABCB1 p.Gln990Ala
X
ABCB1 p.Gln990Ala 22360349:205:55
status: NEW
view ABCB1 p.Gln990Ala details
ABCB1 p.Ile765Ala
X
ABCB1 p.Ile765Ala 22360349:205:66
status: NEW
view ABCB1 p.Ile765Ala details
ABCB1 p.Ile864Ala
X
ABCB1 p.Ile864Ala 22360349:205:48
status: NEW
view ABCB1 p.Ile864Ala details
ATP hydrolysis by the wild type and Pgp mutants I864A, Q990A, and I765A, in isolated membrane vesicles, was conducted either after preincubation with 50 μM verapamil (top) or with 50 μM cis-(Z)-flupentixol (bottom) followed by incubation with increasing concentrations of cis-(Z)-flupentixol (top) or verapamil (bottom), using the vanadate-sensitive phosphate release assay. Login to comment
224 ABCB1 p.Val988Ala
X
ABCB1 p.Val988Ala 22360349:224:32
status: NEW
view ABCB1 p.Val988Ala details
ABCB1 p.Met986Ala
X
ABCB1 p.Met986Ala 22360349:224:21
status: NEW
view ABCB1 p.Met986Ala details
ABCB1 p.Phe983Ala
X
ABCB1 p.Phe983Ala 22360349:224:14
status: NEW
view ABCB1 p.Phe983Ala details
Substitutions F983A, M986A, and V988A completely abrogate stimulation of substrate binding (Figure 2) with only modest effects on ATP-site stimulation (Figure 4), which indicates that the two modulatory events are not tightly coupled to each other. Login to comment
225 ABCB1 p.Ile864Ala
X
ABCB1 p.Ile864Ala 22360349:225:56
status: NEW
view ABCB1 p.Ile864Ala details
ABCB1 p.Thr837Ala
X
ABCB1 p.Thr837Ala 22360349:225:46
status: NEW
view ABCB1 p.Thr837Ala details
Similarly, a reciprocal effect was evident in T837A and I864A, where a 34-fold stimulation of substrate binding was retained (Figure 2) even though ATP-site stimulation was almost abrogated (Figure 4). Login to comment